These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy. Jefferys D; Copolov D; Funder JW Eur J Pharmacol; 1984 Aug; 103(3-4):205-10. PubMed ID: 6489441 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids, adrenal medullary opioids, and the retention of a behavioral response after stress. Jefferys D; Funder JW Endocrinology; 1987 Sep; 121(3):1006-9. PubMed ID: 3622371 [TBL] [Abstract][Full Text] [Related]
4. D-Ala2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats. De Souza EB; Van Loon GR Endocrinology; 1982 Nov; 111(5):1483-90. PubMed ID: 6290184 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids facilitate the retention of acquired immobility during forced swimming. Veldhuis HD; De Korte CC; De Kloet ER Eur J Pharmacol; 1985 Sep; 115(2-3):211-7. PubMed ID: 4065208 [TBL] [Abstract][Full Text] [Related]
6. Neurotrophic peptide ACTH-(4-10) permits glucocorticoid-facilitated retention of acquired immobility response of hypophysectomized rats. De Kock S; De Kloet ER Eur J Pharmacol; 1987 Sep; 141(3):461-6. PubMed ID: 2822451 [TBL] [Abstract][Full Text] [Related]
7. Both adrenal opioids and glucocorticoids involved in the incorporation of information into memory post-stress. Jefferys D; Funder JW NIDA Res Monogr; 1986; 75():501-4. PubMed ID: 3123968 [No Abstract] [Full Text] [Related]
8. A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomy. Jefferys D; Boublik J; Funder JW Eur J Pharmacol; 1985 Jan; 107(3):331-5. PubMed ID: 2984011 [TBL] [Abstract][Full Text] [Related]
9. Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites. De Kloet ER; De Kock S; Schild V; Veldhuis HD Neuroendocrinology; 1988 Feb; 47(2):109-15. PubMed ID: 3344063 [TBL] [Abstract][Full Text] [Related]
10. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria. Wong-Dusting HK; Rand MJ Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945 [TBL] [Abstract][Full Text] [Related]
11. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive beta-endorphin: effects of diurnal variation, adrenalectomy, corticosteroids, and opiate agonists and antagonists. Lim AT; Funder JW Neuroendocrinology; 1983; 36(3):225-34. PubMed ID: 6300719 [TBL] [Abstract][Full Text] [Related]
12. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion. Hashimoto K; Suemaru S; Hattori T; Takao T; Inoue H; Sugawara M; Kageyama J; Ota Z Endocrinol Jpn; 1986 Dec; 33(6):813-20. PubMed ID: 3034557 [TBL] [Abstract][Full Text] [Related]
13. Methionine oxidation enhances opioid activity of an enkephalin analog. Kiritsy-Roy JA; Chan SK; Iwamoto ET Life Sci; 1983 Feb; 32(8):889-93. PubMed ID: 6131372 [TBL] [Abstract][Full Text] [Related]
14. CNS involvement in the antisecretory action of [Met5]enkephalinamide on the rat intestine. Brown DR; Miller RJ Eur J Pharmacol; 1983 Jun; 90(4):441-4. PubMed ID: 6884432 [TBL] [Abstract][Full Text] [Related]
15. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide. Jhamandas K; Sutak M Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736 [TBL] [Abstract][Full Text] [Related]
16. Thyroid hormones and glucocorticoids act synergistically in the regulation of the low affinity glucocorticoid binding sites in the male rat liver. Chirino R; Fernández L; López A; Navarro D; Rivero JF; Díaz-Chico JC; Díaz-Chico BN Endocrinology; 1991 Dec; 129(6):3118-24. PubMed ID: 1954893 [TBL] [Abstract][Full Text] [Related]
17. Effects of mineralocorticoids and glucocorticoids on compensatory adrenal growth in rats. Phillips R; Crock C; Funder J Am J Physiol; 1985 Apr; 248(4 Pt 1):E450-6. PubMed ID: 3985143 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan. Chipkin RE; Latranyi MZ; Iorio LC; Barnett A Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941 [TBL] [Abstract][Full Text] [Related]
19. The forced swimming test: effects of glucose administration on the response to food deprivation and adrenalectomy. Jefferys D; Funder JW Eur J Pharmacol; 1991 Dec; 205(3):267-9. PubMed ID: 1817963 [TBL] [Abstract][Full Text] [Related]
20. D-Ala2-Met5-enkephalinamide impairs the acquisition of ethanol preference without influencing sucrose preference. Sandi C; Borrell J; Guaza C Physiol Behav; 1990 Sep; 48(3):435-9. PubMed ID: 2176293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]